Arcutis Biotherapeutics Inc (ARQT)
9.30
-0.26
(-2.72%)
USD |
NASDAQ |
Jul 02, 16:00
9.30
0.00 (0.00%)
After-Hours: 06:35
Arcutis Biotherapeutics Accounts Receivable (Quarterly): 37.15M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 37.15M |
December 31, 2023 | 25.81M |
September 30, 2023 | 19.42M |
June 30, 2023 | 17.21M |
March 31, 2023 | 12.77M |
Date | Value |
---|---|
December 31, 2022 | 8.458M |
September 30, 2022 | 2.431M |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
37.15M
Maximum
Mar 2024
15.41M
Average
14.99M
Median
Accounts Receivable (Quarterly) Benchmarks
Heron Therapeutics Inc | 65.32M |
Marinus Pharmaceuticals Inc | 3.513M |
Amgen Inc | 6.776B |
Pfizer Inc | 10.99B |
Agios Pharmaceuticals Inc | 3.453M |